Brain V12 Predicts Radiation-Induced Adverse Events and Late Complications After Stereotactic Radiosurgery for Brain Arteriovenous Malformations.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 41690556.
- Also identified by DOI 10.1016/j.ijrobp.2026.02.202.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stereotactic radiosurgery (SRS) is an effective treatment for brain arteriovenous malformations (AVMs), though radiation-induced adverse events (RAEs)-including peri-nidal T2 signal changes and late radiation-induced complications (LRICs)-remain concerns. We evaluated whether brain V12 (volume of surrounding brain receiving ≥12 Gy) predicts RAEs, including chronic encapsulated hematoma and cyst formation. We retrospectively reviewed 317 patients who underwent SRS at a single institution between 1998 and 2020. Large AVMs with a nidus volume ≥10 mL were excluded. The primary outcome was the incidence of RAEs. Predictors of RAEs were identified using Cox proportional hazards models. Secondary outcomes included AVM obliteration and post-SRS hemorrhage. The optimal brain V12 cutoff for predicting symptomatic RAEs at 60 months post-SRS was identified using receiver operating characteristic analysis. The cohort included 176 males (56%), and 137 patients (43%) had prior hemorrhage. Median follow-up was 68 months (interquartile range [IQR], 30-133). Peri-nidal T2 signal changes occurred in 149 patients (47%), including 129 (41%) transient and 20 (6%) permanent. Brain V12 was significantly associated with both transient (hazard ratio [HR], 1.09; 95% confidence interval [CI], 1.04-1.13; P < .01) and permanent (HR, 1.15; 95% CI, 1.07-1.24; P < .01) T2 changes. LRICs occurred in 15 patients (5%) at a median of 92 months (IQR, 59-140) and were more common in those with permanent T2 changes (40% vs 5%, P < .01) and higher brain V12 (median 3.44 vs 2.78 mL, P = .04). Brain V12 was an independent predictor of symptomatic RAEs (HR, 1.21; 95% CI, 1.14-1.28, P < .01), with an interpretable reference of 4.5 mL. Five-year cumulative AVM obliteration rate was 89%, and post-SRS hemorrhage rate was 4 per 1000 patient-years. Brain V12 is a strong predictor of peri-nidal T2 signal changes, LRICs, and symptomatic RAEs. Limiting brain V12 may reduce complications while maintaining treatment efficacy.